Source map — Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| NBC News | news | 60% |
| Fierce Biotech | news | 60% |
| CNBC | news | 60% |
| Eli Lilly | news | 60% |
| The Guardian | news | 60% |
| USA Today | news | 60% |
| www.thebionews.net | news | 50% |
| abc13.com | news | 50% |
| luxaralabs.com | news | 50% |
| tirzepatidereview.com | news | 50% |
| romickinoakley.wordpress.com | news | 50% |
| trials.lilly.com | news | 50% |
| retatrutidereport.com | news | 50% |
| peptoclinic.com | news | 50% |
| retatrutide.med | news | 50% |
| kures.co | news | 50% |
| welltica.com | news | 50% |
| beautybypeptides.com | news | 50% |
| www.biospace.com | news | 50% |
| abcnews.com | news | 50% |
| nypost.com | news | 50% |
| www.yahoo.com | news | 50% |
| onthepen.com | news | 50% |
| www.scientificamerican.com | news | 50% |
| www.prnewswire.com | news | 50% |
| theclinicaltimes.com | news | 50% |
| en.wikipedia.org | news | 50% |
| careers.lilly.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.medicaldaily.com | news | 50% |
| www.technologyreview.com | news | 50% |
| www.newsweek.com | news | 50% |
| www.glp3.wiki | news | 50% |
| www.matterfact.com | news | 50% |
| www.onedaymd.com | news | 50% |
| glpplaybook.com | news | 50% |
| pepsreview.com | news | 50% |
| www.retaweightloss.com | news | 50% |
| remyresearch.com | news | 50% |